4.5 Article

Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF Trial

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Pragmatic Design of Randomized Clinical Trials for Heart Failure Rationale and Design of the TRANSFORM-HF Trial

Stephen J. Greene et al.

Summary: Randomized clinical trials in heart failure populations have faced challenges like slow patient enrollment and high costs. The traditional model for HF trials is difficult to execute in the United States, leading to modest US representation in global trials. The TRANSFORM-HF trial aims to compare the effects of torsemide versus furosemide among HF patients in the US.

JACC-HEART FAILURE (2021)

Editorial Material Cardiac & Cardiovascular Systems

Trends in Place of Death for Individuals With Cardiovascular Disease in the United States

Sarah H. Cross et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Letter Medicine, General & Internal

Changes in the Place of Death in the United States

Sarah H. Cross et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

The PRECIS-2 tool: designing trials that are fit for purpose

Kirsty Loudon et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Article Medicine, General & Internal

The PRECIS-2 tool: designing trials that are fit for purpose

Kirsty Loudon et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)